Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

  1. Battipaglia, G.
  2. Mauff, K.
  3. Wendel, L.
  4. Angelucci, E.
  5. Mohty, M.
  6. Arcese, W.
  7. Santarone, S.
  8. Rubio, M.T.
  9. Kroger, N.
  10. Fox, M.L.
  11. Blaise, D.
  12. Iori, A.P.
  13. Fanin, R.
  14. Chalandon, Y.
  15. Pioltelli, P.
  16. Marotta, G.
  17. Chiusolo, P.
  18. Sever, M.
  19. Solano, C.
  20. Contentin, N.
  21. de Wreede, L.C.
  22. Czerw, T.
  23. Hernandez-Boluda, J.C.
  24. Hayden, P.
  25. McLornan, D.
  26. Yakoub-Agha, I.
  27. Montrer des auteurs +
Revue:
Bone Marrow Transplantation

ISSN: 1476-5365 0268-3369

Année de publication: 2021

Volumen: 56

Número: 7

Pages: 1593-1602

Type: Article

DOI: 10.1038/S41409-021-01222-Z GOOGLE SCHOLAR